Bacterin International Holdings (BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Bacterin's Medical Device division develops, employs and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination.
(click to enlarge)
Insider buys
Guy Cook purchased 5,000 shares on September 11 and 95,451 shares during May 9 - June 8 period. Guy Cook owns 25.2% of the company. Guy Cook serves as a Chairman of the board, CEO and President of the company. Kent Swanson purchased 27,977 shares on June 11 and currently controls 450,000 shares of the company. Kent Swanson serves as a Director and Compensation Committee Chairman. Jon Wickwire purchased 20,000 shares on May 8 and currently controls 363,139 shares of the company. Jon Wickwire serves as a Director and Chairman of Corporate Governance and Nominating Committees.
Market Data 
Markets 
AI
